24/7 Customer Support
Japan Epigenetics Market is estimated to witness a rise in revenue from US$ 23.6 Mn in 2021 to US$ 48.6 Mn by 2027. The market is registering at a CAGR of 12.8% during the forecast period 2022-2027.
Epigenetics is a branch of genetics concerned with the study of cellular and physiological trait variations caused by behaviors and environmental factors that impact the way the persons genes work. Moreover, epigenetics market growth is primarily attributed to the increasing number of chronic diseases that requires a high amount of medical examination, coupled with the technological enhancements in treatment. Also, the growing geriatric population, increasing demand for R&D activities and favorable government supports for epigenetics procedures is creating a huge demand for the market of epigenetics. Furthermore, the growing technological advancements such as AI and adoption of machine learning in epigenetics has shown a tremendous growth opportunity for the market.
The major factor responsible for the growth of the Japan epigenetics market includes growing of R&D expenditure in the pharmaceutical & biopharmaceutical industry and growing adoption of epigenetics for cancer treatment. The pharmaceutical industry’s activities have significant socio-economic impacts on society in the form of investments in R&D and manufacturing which results in driving the growth of drug discovery services, thereby augmenting the epigenetics market. Moreover, epigenetics is a way to diagnose and treat cancer and other conditions, as it to work well with radiation and chemotherapy as these drugs may make cancer cells more sensitive to these therapies. Furthermore, the rising number of initiatives taken by government bodies, universities and pharmaceutical and biotechnology companies in order to encourage researches related to epigenetics is one of the major factors which positively impact market growth in the Japan. However, high costs of epigenetics instruments and dearth of skilled workforce hinder their wide adoption, which is expected to restrict market growth during the forecast period.4
The study of the Japan Epigenetics Market considers various market determinants, industry value chain analysis and competitor analysis of the market. The report discusses the analysis of the epigenetics industry for the period 2017-2027, where the base year is 2021 and the forecast period is 2022-2027. The report provides a detailed analysis of the Japan Epigenetics Market across 9 Chapters and 82 pages. The report includes data presentation across 8 tables and 23 statistical figures.
The report provides PESTLE analysis, which is a tool to examine the external market environment factors that have an impact on the industry. The PESTLE analysis examines the Political, Economic, Social, Technological, Environmental and Legal factors in the external environment. Thus, sufficiently examining the threats and weaknesses of the industry. The research report also provides Porter’s five forces analysis wherein bargaining power of buyers and competitive rivalry is high.
The subsequent section provides details of the market analysis based on different segments such as product type, technology, application, end-users. The report includes detailed study of value chain of the industry. It includes raw material providers, manufacturing, distributors and end users. The report also covers extensively about the key competitors in the market for epigenetics.
Japan Epigenetics market is expected to witness a slight decline of approx. 3.2% in 2020, in the recent outbreak of the COVID-19 pandemic. The novel COVID-19 has seen a significant impact on the epigenetics market. Every element has been affected, from raw material supplier to manufacturer and other end users. Factories and production facility have been forced to remain closed due to lockdown and social distancing measures, resulting in a sharp drop in the sales of epigenetic services, instrument and others. Moreover, epigenetics devices and instrument manufacturers rely on supply chain, over-rely on suppliers of key components and their weak negotiation power will lead to high precision components and others. Furthermore, the significant decline in skilled professionals and a decrease in research activity due to laboratory closures and reduced clinical testing have all affected the epigenetics products market.
However, the market will gain its traction with the investments in new technologies like adoption of automated devices with the implementation of AI and machine learning, which will foster the epigenetics market growth. Nevertheless, post-COVID-19, the demand for epigenetics will further grow at an unprecedented rate, with gradual expansion in the market value during the forecast period.
The key players in the Japan Epigenetics Market are Epigenereon, National Institute of Genetics, Rhelixa Inc., RIKEN, Illumina, Inc., Daiichi Sankyo Company Limited, Takeda Pharmaceutical Company Limited and Abcam PLC among others. Through extensive research, it is found that big players have adopted various competitive strategies such as mergers & acquisitions in order to have a grip of emerging market. Furthermore, leading companies are expanding their geographical boundaries by acquiring small brands and domestic companies.
Japan Epigenetics Market is segmented based on product type, technology, application, end-users and country. The industry trends in the epigenetics market are sub-divided into different categories in order to get a holistic view of the Japan marketplace.
By Technology segment of the Japan Epigenetics Market is sub-segmented into:
By Application segment of the Japan Epigenetics Market is sub-segmented into:
By End-Users segment of the Japan Epigenetics Market is sub-segmented into:
Epigenetics is a branch of genetics concerned with the study of cellular and physiological trait variations caused by environmental or ecological factors that turn genes on and off and influence cellular ability to read genes without being affected by genotype changes.
Biology and genetic expressions of most organisms are affected by epigenetics, which makes it one of the most crucial fields of developmental genetics and molecular biology.
Epigenetic changes are essential for development since they are dynamic and change in response to external stimuli.
The expected growth rate of the Japan epigenetics market is 12.8%, with an estimated value of US$ 48.6 Million by 2027.
Factors such as growing R&D expenditure in the pharmaceutical & biopharmaceutical industry and growing adoption of epigenetics for cancer treatment will boost the Japan epigenetics market during the forecast period.
The novel COVID-19 has seen a significant impact on the epigenetics market. Japan epigenetics market is witnessed a slight decline of approx. 3.2% in 2020, in the recent outbreak of the COVID-19 pandemic.
Based on technology, the epigenetics market is segmented into DNA methylation, histone methylation, histone acetylation, bromodomains, non-coding RNA and others.
High cost of epigenetics instruments and dearth of skilled workforce is a restraining factor which inhibits the growth of the epigenetics market during the forecast period.
The oncology segment is expected to project the highest CAGR over the forecast period in the Japan epigenetics market.
Product type, technology, application and end-users are the different segments to invest in over the assessment period in the Japan epigenetics market.
Innovative growth strategies are likely to provides a lucrative growth trend in the Japan epigenetics market.
The key players operating in the market include Epigenereon, National Institute of Genetics, Rhelixa Inc., RIKEN, Illumina, Inc., Daiichi Sankyo Company Limited, Takeda Pharmaceutical Company Limited and Abcam PLC among others.
LOOKING FOR COMPREHENSIVE MARKET KNOWLEDGE? ENGAGE OUR EXPERT SPECIALISTS.SPEAK TO AN ANALYST